COVID-19 CoVPN Protocol 3002/AstraZeneca

Project: Research project

Project Details


A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
Effective start/end date8/27/2011/30/20


  • University of California at Los Angeles (AGREEMENT 1560 B WA693 //)
  • National Institute of Allergy and Infectious Diseases (AGREEMENT 1560 B WA693 //)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.